Topical peptides as cosmeceuticals

Indian Journal of Dermatology, Venereology and Leprology

Volumn 83, Issue 1, 2017, Pages 9-18

  Pai, Varadraj ^a   Bhandari, Prasana ^b   Shukla, Pankaj ^a  

^a GOA MEDICAL COLLEGE   (India)

^b SDM COLLEGE OF MEDICAL SCIENCES AND HOSPITAL   (India)

Author keywords

Cosmeceuticals; dermatotherapeutics; topical peptides

Indexed keywords

ACETYLCHOLINE; ALPHA INTERFERON; BOTULINUM TOXIN; COSMECEUTICAL; MATRIX METALLOPROTEINASE; MELANIN; OLIGOPEPTIDE; PEPTIDE; COSMETIC; PEPTIDE FRAGMENT;

CHEMOTAXIS; DERMATOLOGY; EXTRACELLULAR MATRIX; HOMEOSTASIS; HUMAN; IMMUNOGENICITY; INFLAMMATION; INNATE IMMUNITY; REPRODUCTION; REVIEW; TOPOGRAPHY; WRINKLE; ANIMAL; CHEMISTRY; DRUG EFFECTS; SKIN ABSORPTION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; COSMECEUTICALS; COSMETICS; HUMANS; PEPTIDE FRAGMENTS; PEPTIDES; SKIN ABSORPTION;

EID: 85004073289     PISSN: 03786323     EISSN: 09733922     Source Type: Journal    
DOI: 10.4103/0378-6323.186500     Document Type: Review

References (60)

1. Uhlig T, Kyprianou T, Martinelli FG, Oppici CA, Heiligers D, Hills D, et al. The emergence of peptides in the pharmaceutical business: From exploration to exploitation. EuPA Open Proteom 2014;4:58-69
2. Reddy B, Jow T, Hantash BM. Bioactive oligopeptides in dermatology: Part I. Exp Dermatol 2012;21:563-8
3. Zhang L, Falla TJ. Cosmeceuticals and peptides. Clin Dermatol 2009;27:485-94
4. López-Otín C, Matrisian LM. Emerging roles of proteases in tumour suppression. Nat Rev Cancer 2007;7:800-8
5. Bruno BJ, Miller GD, Lim CS. Basics and recent advances in peptide and protein drug delivery. Ther Deliv 2013;4:1443-67
6. Kligman AM. Cosmetics. A dermatologist looks to the future: Promises and problems. Dermatol Clin 2000;18:699-709
7. Peptide Therapeutics Market (by Applications, by Route of Administration, and by Marketing Status)-Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014-2020; April, 2015. Available from: http://www.transparencymarketresearch.com/pressrelease/peptide-therapeutics-market.htmd. [Last cited on 2015 Oct 01]
8. Global Cosmeceuticals Market Outlook 2020. RNCOS E-Services Pvt. Ltd.; July, 2015. Available from: http://www.giiresearch.com/report/rnc263147-global-cosmeceutical-market-outlook.html. [Last cited on 2015 Oct 01]
9. Gorouhi F, Maibach HI. Role of topical peptides in preventing or treating aged skin. Int J Cosmet Sci 2009;31:327-45
10. Katayama K, Seyer JM, Raghow R, Kang AH. Regulation of extracellular matrix production by chemically synthesized subfragments of type I collagen carboxy propeptide. Biochemistry 1991;30:7097-104
11. Katayama K, Armendariz-Borunda J, Raghow R, Kang AH, Seyer JM. A pentapeptide from type I procollagen promotes extracellular matrix production. J Biol Chem 1993;268:9941-4
12. Choi YL, Park EJ, Kim E, Na DH, Shin YH. Dermal stability andin vitro skin permeation of collagen pentapeptides (KTTKS and palmitoyl-KTTKS). Biomol Ther (Seoul) 2014;22:321-7
13. Lau WM, White AW, Gallagher SJ, Donaldson M, McNaughton G, Heard CM. Scope and limitations of the co-drug approach to topical drug delivery. Curr Pharm Des 2008;14:794-802
14. Pouillot A, Dayan N, Polla AS, Polla LL, Polla BS. The stratum corneum: A double paradox. J Cosmet Dermatol 2008;7:143-8
15. Osborne R, Robinson LR, Mullins L, Raleigh PZ. Use of a facial moisturizer containing palmitoyl pentapeptide improves the appearance of aging skin. J Am Acad Dermatol 2005;52:96
16. ECM-Protect. Technical File. Lucas Meyer Cosmetics. Available from: http://www.lucameyercosmetics.comECMprotecttechnicalfilea.pdf. [Last accessed on 2015 Aug 23]
17. Loing E, Suere T, Lamarque E. Trifluoroacetyl-tripeptide-2 to target senescence for anti-aging benefits. Cosmet Toiletries 2012;127:274-81
18. SYN-COLL. Penta Pharm. Available from: http://www.lotioncrafter.com/refrence/techdatasyncoll.pdf. [Last accessed on 2015 Aug 23]
19. Puig A, Antón JM, Mangues M. A new decorin-like tetrapeptide for optimal organization of collagen fibres. Int J Cosmet Sci 2008;30:97-104
20. Sadick NS. Futuristic approach in skin care. In: Sadick NS, Lupo M, Berson DS, Draelos ZD, editors. Cosmeceutical Science in Clinical Practice. Florida: Taylor and Francis Group, CBC Press; 2010. p. 96
21. Peptamide 6. Cosmetics Ingredients and Ideas. Arch Personalcare Products, L.P. Version 04/22/08v1.6. Available from: http://www.lipocol.com/applications/lipocolombia/archivos/226INFORM-ACINTCNICA.pdf. [Last accessed on 2015 Aug 28]
22. Njieha FK, Morikawa T, Tuderman L, Prockop DJ. Partial purification of a procollagen C-proteinase. Inhibition by synthetic peptides and sequential cleavage of type I procollagen. Biochemistry 1982;21:757-64
23. Rodrigues AL, Benoit I, Clarius T, Pauly G. Counteracting ageing phenomena by new pure tetrapeptides with targeted efficacy. J Appl Cosmetol 2009;27:63-71
24. Pauly G, Contet-Audonneau J, Moussou P, Danoux L, Bardey V, Freis O. et al. Small proteoglycans in the skin: New targets in the fight against aging. Int Fed Soc Cosmet Chem 2008;11:21-9
25. Farwick M, Grether-Beck S, Marini A, Maczkiewitz U, Lange J, Köhler T, et al. Bioactive tetrapeptide GEKG boosts extracellular matrix formation:In vitro andin vivo molecular and clinical proof. Exp Dermatol 2011;20:602-4
26. Eyeseryl Peptide. Lipotec. Available from: http://www.lipotec.com/en/products/eyeseryl-reg-peptide.pdf. [Last accessed on 2015 Aug 26]
27. Eyeliss TM. Sederma. Available from: http://www.longmidai.com/html/eyeliss.pdf. [Last accessed on 2015 Aug 26]
28. Jungersted JM, Bomholt J, Bajraktari N, Hansen JS, Klærke DA, Pedersen PA, et al. In vivo studies of aquaporins 3 and 10 in human stratum corneum. Arch Dermatol Res 2013;305:699-704
29. Dumas M, Sadick NS, Noblesse E, Juan M, Lachmann-Weber N, Boury-Jamot M, et al. Hydrating skin by stimulating biosynthesis of aquaporins. J Drugs Dermatol 2007;6 6 Suppl: s20-4
30. Ehrlich M, Rao J, Pabby A, Goldman MP. Improvement in the appearance of wrinkles with topical transforming growth factor beta (1) and l-ascorbic acid. Dermatol Surg 2006;32:618-25
31. Gold MH, Goldman MP, Biron J. Human growth factor and cytokine skin cream for facial skin rejuvenation as assessed by 3Din vivo optical skin imaging. J Drugs Dermatol 2007;6:1018-23
32. Tutar L, Tutar Y. Heat shock proteins; an overview. Curr Pharm Biotechnol 2010;11:216-22
33. Dal Farra C, Bauza E, Domloge N. Heat shock proteins for cosmeceuticals. In: Elsner P, Maibach HI, editors. Cosmeceuticals and Active Cosmetics. Vol. 55. New York: Marcel Dekker; 2005. p. 523-36
34. Gabai VL, Meriin AB, Mosser DD, Caron AW, Rits S, Shifrin VI, et al. Hsp70 prevents activation of stress kinases. A novel pathway of cellular thermotolerance. J Biol Chem 1997;272:18033-7
35. Ghersetich I, Comacchi C, Lotti T. Immunohistochemical and ultrastructural investigation of multiple common warts before and after therapy with alpha-interferon. G Ital Dermatol Venereol 1992;127:207-10
36. Ghersetich I, Lotti T. Alpha-Interferon cream restores decreased levels of Langerhans/indeterminate (CD1a+) cells in aged and PUVA-treated skin. Skin Pharmacol 1994;7:118-20
37. Katz BE, Bruck MC. Efficacy and tolerability of Kinetin 0.1% cream for improving the signs of photo aging in facial and neck skin. Cosmet Dermatol 2006;19:736-41
38. Abdel-Malek ZA, Kadekaro AL, Kavanagh RJ, Todorovic A, Koikov LN, McNulty JC, et al. Melanoma prevention strategy based on using tetrapeptide alpha-MSH analogs that protect human melanocytes from UV-induced DNA damage and cytotoxicity. FASEB J 2006;20:1561-3
39. Hantash BM, Jimenez F. A split-face, double-blind, randomized and placebo-controlled pilot evaluation of a novel oligopeptide for the treatment of recalcitrant melasma. J Drugs Dermatol 2009;8:732-5
40. Ramaiah A, Puri N, Mojamdar M. Etiology of vitiligo. A new hypothesis. Acta Derm Venereol 1989;69:323-6
41. Barba C, Méndez S, Roddick-Lanzilotta A, Kelly R, Parra JL, Coderch L. Cosmetic effectiveness of topically applied hydrolysed keratin peptides and lipids derived from wool. Skin Res Technol 2008;14:243-8
42. Barba C, Méndez S, Roddick-Lanzilotta A, Kelly R, Parra JL, Coderch L. Wool peptide derivatives for hand care. J Cosmet Sci 2007;58:99-107
43. Fernandes MM, Lima CF, Loureiro A, Gomes AC, Cavaco-Paulo A. Keratin-based peptide: Biological evaluation and strengthening properties on relaxed hair. Int J Cosmet Sci 2012;34:338-46
44. Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett 1988;238:343-6
45. Leyden JJ, Stevens T, Finkey MB, Barkovic S. Skin care benefits of copper peptide containing facial cream. American Academy of Dermatology 60th Annual Meeting. New Orleans, LA; 2002. p. 22-7
46. Finkey MB, Appa Y, Bhandarkar S. Copper peptide and skin. In: Elsner P, Maibach HI, editors. Cosmeceuticals and Active Cosmetics. 2nd ed. New York: Marcel Dekker; 2005. p. 549-64
47. 2014 Plastic Surgery Statistics Report. ASPS National Clearinghouse of Plastic Surgery Procedural Statistics. American Society of Plastic Surgeons; 2015. Available from: http://www.plasticsurgery.org/documents/news-resources/statistics/2014-statistics/cosmetic-procedure-trends-2014.pdf. [Last cited on 2015 Oct 01]
48. Collins A, Nasir A. Topical botulinum toxin. J Clin Aesthet Dermatol 2010;3:35-9
49. RT001. Lateral Canthi Line. Revenge Therapeutics. Available from: http://www.revance.com/rt001-lateral-canthal-lines.html. [Last accessed on 2015 Sep 03]
50. Bonifacino JS, Glick BS. The mechanisms of vesicle budding and fusion. Cell 2004;116:153-66
51. RT001. Mechanism for Delivery of Botulin Toxin. Revenge Therapeutics. Available from: http://www.revance.com/mechanism-of-action-rt001.html. [Last accessed on 2015 Oct 01]
52. Reddy BY, Jow T, Hantash BM. Bioactive oligopeptides in dermatology: Part II. Exp Dermatol 2012;21:569-75
53. Brandt F, O'Connell C, Cazzaniga A, Waugh JM. Efficacy and safety evaluation of a novel botulinum toxin topical gel for the treatment of moderate to severe lateral canthal lines. Dermatol Surg 2010;36 Suppl 4:2111-8
54. Blanes-Mira C, Clemente J, Jodas G, Gil A, Fernández-Ballester G, Ponsati B, et al. Asynthetic hexapeptide (argireline) with antiwrinkle activity. Int J Cosmet Sci 2002;24:303-10
55. Südel KM, Venzke K, Mielke H, Breitenbach U, Mundt C, Jaspers S, et al. Novel aspects of intrinsic and extrinsic aging of human skin: Beneficial effects of soy extract. Photochem Photobiol 2005;81:581-7
56. Sim GS, Lee DH, Kim JH, An SK, Choe TB, Kwon TJ, et al. Black rice (Oryza sativa L. var. japonica) hydrolyzed peptides induce expression of hyaluronan synthase 2 gene in HaCaT keratinocytes. J Microbiol Biotechnol 2007;17:271-9
57. Zhaorigetu S, Yanaka N, Sasaki M, Watanabe H, Kato N. Inhibitory effects of silk protein, servicing on UVB-induced acute damage and tumour promotion by reducing oxidative stress in the skin of hairless mouse. J Photochem Photobiol B Biol 2003;71:11-7
58. Choi CM, Berson DS. Cosmeceuticals. Semin Cutan Med Surg 2006;25:163-8
59. Marepally S, Boakye CH, Shah PP, Etukala JR, Vemuri A, Singh M. Design, synthesis of novel lipids as chemical permeation enhancers and development of nanoparticle system for transdermal drug delivery. PLoS One 2013;8:e82581
60. Kalluri H, Banga AK. Transdermal delivery of proteins. AAPS Pharm Sci Tech 2011;12:431-41